GlassScriptPhysician profile
Jonathan Cohen
NPI 1790709533
$93,542.07
in general payments reported to CMS, 2019-2025
43 companies · $1,691 in 2025
The $1,691 reported for 2025 was more than what 75% of Gastroenterology (Internal Medicine) providers received nationally (typical 2025 total: $636).
See the full distribution for Gastroenterology (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $61K · 2020: $13K · 2021: $2,652 · 2022: $3,787 · 2023: $7,847 · 2024: $4,097 · 2025: $1,691.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $8,833 · Food and Beverage: $3,492 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $923 · Travel and Lodging: $389.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $8,832.50 |
| Food and Beverage | $3,491.79 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $922.50 |
| Travel and Lodging | $389.16 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Olympus Latin America, INC. | $48,879.80 | 2019-2020 | |
| Otsuka America Pharmaceutical, INC. | $15,268.23 | 2019 | |
| Olympus Corporation | $7,687.50 | 2021-2023 | Evis Exera III Video System Center |
| Ferring Pharmaceuticals INC. | $3,089.94 | 2019-2025 | Clenpiq |
| Gilead Sciences, INC. | $2,771.39 | 2019-2023 | Vemlidy |
| Olympus Medical Systems Corporation | $2,570.00 | 2024-2025 | |
| Olympus Corporation of The Americas | $2,238.82 | 2019 | |
| Abbvie INC. | $1,994.90 | 2021-2024 | Skyrizi, Rinvoq, Linzess |
| Braintree Laboratories, INC. | $1,833.76 | 2019-2024 | Sutab, Suflave |
| Micro-Tech Endoscopy USA, INC. | $1,620.96 | 2019-2024 | Sta-Bil, Flat Wire Snares, Edgehog |
| Celgene Corporation | $802.45 | 2021-2024 | Zeposia |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $775.76 | 2019-2023 | Trulance |
| Qol Medical, LLC | $607.53 | 2019-2023 | Sucraid |
| Janssen Biotech, INC. | $574.35 | 2019-2023 | Stelara |
| Ferring Pty LTD | $389.16 | 2023 |
Show all 43 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $336.51 | 2019-2025 | |
| Merck Sharp & Dohme LLC | $331.26 | 2019-2023 | Dificid |
| Pentax of America, INC. | $300.42 | 2023-2024 | Pentax Medical, C2 Cryoballoon, Inspira |
| Medtronic, INC. | $290.49 | 2021-2025 | Gi Genius |
| Takeda Pharmaceuticals U.S.A., INC. | $277.39 | 2019-2022 | |
| Daiichi Sankyo INC. | $112.40 | 2019-2024 | Injectafer |
| Olympus America INC. | $102.68 | 2024 | |
| Intercept Pharmaceuticals, INC. | $100.00 | 2019-2023 | Ocaliva |
| Covidien LP | $81.30 | 2019 | |
| Ironwood Pharmaceuticals, INC | $70.62 | 2019-2020 | |
| Janssen Scientific Affairs, LLC | $56.37 | 2020-2021 | |
| Allergan, INC. | $51.66 | 2019 | |
| Laborie Medical Technologies Corp. | $36.96 | 2023 | |
| Novo Nordisk INC | $29.85 | 2025 | Wegovy |
| Amgen INC. | $26.09 | 2025 | Uplizna |
| Organon LLC | $24.54 | 2023 | Renflexis, Hadlima |
| Exact Sciences Corporation | $24.43 | 2025 | Cologuard Collection Kit |
| Capsovision, INC. | $22.49 | 2024 | Capsocam Plus |
| Nestle Healthcare Nutrition INC. | $21.83 | 2023 | |
| W. L. Gore & Associates, INC. | $19.71 | 2022 | |
| Alfasigma USA, INC. | $19.53 | 2020 | |
| Lilly USA, LLC | $17.15 | 2024 | Zepbound |
| Phadia US INC. | $16.97 | 2019 | |
| Romark Laboratories, Lc | $16.12 | 2019 | |
| Endo Pharmaceuticals INC. | $15.74 | 2021 | |
| Amarin Pharma, INC. | $14.48 | 2019 | |
| Aimmune Therapeutics, INC. | $13.47 | 2024 | |
| Apollo Endosurgery US INC | $7.06 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jonathan Cohen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.